Cargando…

An increased severity of peripheral arterial disease in the COVID-19 era

Detalles Bibliográficos
Autores principales:	Sena, Giuseppe, Gallelli, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the Society for Vascular Surgery. Published by Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192106/ https://www.ncbi.nlm.nih.gov/pubmed/32360372 http://dx.doi.org/10.1016/j.jvs.2020.04.489

Ejemplares similares

Cardiac Rehabilitation in Patients with Peripheral Artery Disease—A Literature Review in COVID-19 Era
por: Anghel, Razvan, et al.
Publicado: (2022)

Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes
por: Zierfuss, Bernhard, et al.
Publicado: (2019)

COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era
por: Taga, Arens, et al.
Publicado: (2022)

Role of surgical treatment for peripheral arterial disease in endovascular era
por: Park, Sang Jun, et al.
Publicado: (2013)

A new era of medical therapy for peripheral artery disease
por: Casella, Ivan Benaduce, et al.
Publicado: (2020)

The Role of MMPs in the Era of CFTR Modulators: An Additional Target for Cystic Fibrosis Patients?
por: Esposito, Renata, et al.
Publicado: (2023)

The Limitations of Social Behaviour Imposed by CoVid-19 Impacted the Perception and the Evolution of Peripheral Arterial Disease Negatively
por: de Donato, Gianmarco, et al.
Publicado: (2021)

The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?
por: Badagliacca, Roberto, et al.
Publicado: (2022)

The “Microbiome”: A Protagonist in COVID-19 Era
por: Merra, Giuseppe, et al.
Publicado: (2022)

Peripheral artery disease: potential role of ACE-inhibitor therapy
por: Coppola, Giuseppe, et al.
Publicado: (2008)

Impact of COVID-19 on Peripheral Arterial Disease Treatment
por: Li, Wenrui, et al.
Publicado: (2020)

Sleep apnoea is common in severe peripheral arterial disease
por: Schahab, Nadjib, et al.
Publicado: (2017)

The “Intermediate” CD14(++)CD16(+) monocyte subset increases in severe peripheral artery disease in humans
por: Wildgruber, Moritz, et al.
Publicado: (2016)

Vaccinology in the post−COVID-19 era
por: Rappuoli, Rino, et al.
Publicado: (2021)

The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization
por: Serra, Raffaele, et al.
Publicado: (2021)

Severe refractory Kawasaki disease in seven infants in the COVID-19 era
por: Vergnano, Stefania, et al.
Publicado: (2020)

Relationship of Inflammatory Biomarkers with Severity of Peripheral Arterial Disease
por: Igari, Kimihiro, et al.
Publicado: (2016)

THE IMPACT OF THE COVID19 PANDEMIC ON PATIENTS WITH PERIPHERAL ARTERY DISEASE
por: Tanaka, John, et al.
Publicado: (2023)

Risk of peripheral arterial thrombosis in COVID-19
por: Mestres, Gaspar, et al.
Publicado: (2020)

Single-Center Experience with Simultaneous Mural Aortic Thrombosis and Peripheral Obstructive Disease in Pre-COVID-19 and COVID-19 Era
por: Benedetto, Filippo, et al.
Publicado: (2023)

COPD is associated with an increased risk of peripheral artery disease and mortality
por: Terzikhan, Natalie, et al.
Publicado: (2018)

Coronavirus disease 2019 (COVID‐19): Focus on peripheral blood cell morphology
por: Zini, Gina, et al.
Publicado: (2022)

Focus on Prevention: Peripheral Arterial Disease and the Central Role of the Cardiologist
por: Fioretti, Vincenzo, et al.
Publicado: (2023)

Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease
por: Noordzij, Marjon J., et al.
Publicado: (2011)

Accuracy of Acceleration Time of Distal Arteries to Diagnose Severe Peripheral Arterial Disease
por: Trihan, Jean-Eudes, et al.
Publicado: (2022)

Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease
por: Andreucci, Michele, et al.
Publicado: (2022)

Managing Severe Aortic Stenosis in the COVID-19 Era
por: Tanguturi, Varsha K., et al.
Publicado: (2020)

Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic
por: Farhan, Serdar, et al.
Publicado: (2021)

Being a foot and ankle surgeon in Italy in the era of COVID-19
por: Usuelli, Federico Giuseppe, et al.
Publicado: (2020)

Microparticles Carrying Sonic Hedgehog Are Increased in Humans with Peripheral Artery Disease
por: Giarretta, Igor, et al.
Publicado: (2018)

Brief letter of a doctor to his psychologist in the COVID-19 outbreak era
por: Santini, Daniele, et al.
Publicado: (2020)

Peripheral Artery Disease Causes More Harm to Patients than COVID-19
por: Kasiri, Mohammad Mahdi, et al.
Publicado: (2022)

Temporal Trends in Patients with Peripheral Artery Disease Influenced by COVID-19 Pandemic
por: Keller, Karsten, et al.
Publicado: (2022)

Asymptomatic carotid artery stenosis in patients with severe peripheral vascular diseases
por: Mirsharifi, Rasoul, et al.
Publicado: (2009)

Hot-water immersion increases popliteal artery shear stress in Peripheral Arterial Disease
por: Thomas, Kate N, et al.
Publicado: (2015)

Diagnostic bias during the COVID-19 era: COVID-19 or renal abscess?
por: Amato, Marco, et al.
Publicado: (2021)

Transradial approach for carotid artery stenting in a patient with severe peripheral arterial disease
por: Maciejewski, Damian, et al.
Publicado: (2014)

Heart team consultations for patients with severe coronary artery disease or valvular heart disease in the era of the COVID-19 pandemic: a single-center experience
por: Jonik, Szymon, et al.
Publicado: (2023)

Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions
por: Canonico, Mario Enrico, et al.
Publicado: (2023)

Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g08n7ust2sqc1909h3j19kq4bh